Clinical Trial Update: Effects of Ublituximab on Motor Functions in Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial is evaluating the effects of ublituximab on motor function in relapsing-remitting multiple sclerosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Ublituximab (ublituximab)

Snippet

Sponsor: Georgia State University | Conditions: Multiple Sclerosis (MS) - Relapsing-remitting | EARLY_Phase 1 | Status: RECRUITING